Latest Drug Development Pilot Awards Announced

Five projects received Drug Development Pilot Awards in the latest round:

Development of UR214-7 and UR214-9 for cancer treatments
Kyu Kwang Kim, Department of Obstetrics and Gynecology

Small Molecule Modulators of U2AF-Dependent Splicing in Myelodysplastic Syndromes
Clara L. Kielkopf, Department of Biochemistry and Biophysics

Innate Immunity guided screening for apicomplexan profilins
Felix Yarovinsky, Department of Microbiology and Immunology

Creation and development of fully-transmembrane receptor effectors
Omar Bakht and Omar Aljitawi, Department of Medicine, Hematology / Oncology

A new alarmin S100A11 in host defense and inflammation
Felix Yarovinsky, Department of Microbiology and Immunology

The Drug Development Pilot Award Program (DDPA) supports projects in drug development research that result in technology development, extramural funding, and commercialization. This program is restricted to SMD faculty and awards funds up to $10,000 or $50,000, depending upon the award type.

To learn more about the DDPA, visit: http://www.rochester.edu/ventures/for-ur-innovators/resources-innovators/drug-development-pilot-award/

Latest Technology Development Fund Awards Announced

The Technology Development Fund (TDF) made four awards in the latest round. Awards ranged from $50,000 – $100,000 for projects of one-year in length.

Interested to learn more about the projects funded in this round? Contact us.

Fiber Array to Silicon Photonic Chip Optical Packaging
Jaime Cardenas, Institute of Optics

Pre-clinical development of a human monoclonal antibody cocktail (URnFluhmAb) for the universal prevention and treatment of influenza infection
James Kobie, Department of Medicine and Luis Martinez-Sobrido, Department of Microbiology & Immunology

Development of URML-3881, a small molecule MEK inhibitor for the treatment of cancers with high MAP kinase pathway activity
Rachael Turner, Department of Hematology/Oncology

Inscriptr Gene Therapy
Douglas Anderson, Department of Medicine

The TDF solicits proposals twice a year. Qualified applicants include University of Rochester faculty, students, or staff who have filed an invention disclosure with UR Ventures. Eligible projects propose the development of a technology to a more commercial endpoint. Awards range from $40,000 to $100,000.

To learn more about the TDF, visit: http://www.rochester.edu/tdf/